Drug Profile
FP 0011
Alternative Names: FP 0011-Backup; FP0011Latest Information Update: 20 Nov 2009
Price :
$50
*
At a glance
- Originator Faust Pharmaceuticals
- Developer Domain Therapeutics
- Class Neuroprotectants; Small molecules
- Mechanism of Action Glutamate antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Amyotrophic lateral sclerosis; Parkinson's disease